RT Journal Article
SR Electronic
T1 Predicting the combined effects of case isolation, safe funeral practices, and contact tracing during Ebola virus disease outbreaks
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.10.06.22280767
DO 10.1101/2022.10.06.22280767
A1 Bouba, Aliou
A1 Helle, Kristina Barbara
A1 Schneider, Kristan Alexander
YR 2022
UL http://medrxiv.org/content/early/2022/10/07/2022.10.06.22280767.abstract
AB Background The recent outbreaks of Ebola virus disease (EVD) in Uganda and the Marburg virus disease in Ghana reflect a persisting threat of Filoviridae to the global health community. Characteristic of Filoviridae are not just their high case fatality rates, but also that corpses are highly contagious and prone to cause infections in the absence of appropriate precautions. Vaccines against the most virulent Ebolavirus species, the Zaire ebolavirus (ZEBOV) are approved. However, there exists no approved vaccine or treatment against the Sudan ebolavirus (SUDV) which causes the current outbreak of EVD. Hence, the control of the outbreak relies on case isolation, safe funeral practices, and contact tracing. So far, the effectiveness of these control measures was studied only separately by epidemiological models, while the impact of their interaction is unclear.Methods and findings To sustain decision making in public health-emergency management, we introduce a predictive model to study the interaction of case isolation, safe funeral practices, and contact tracing. The model is a complex extension of an SEIR-type model, and serves as an epidemic preparedness tool. The model considers different phases of the EVD infections, the possibility of infections being treated in isolation (if appropriately diagnosed), in hospital (if not properly diagnosed), or at home (if the infected do not present to hospital for whatever reason). It is assumed that the corpses of those who died in isolation are buried with proper safety measures, while those who die outside isolation might be buried unsafely, such that transmission can occur during the funeral. Furthermore, the contacts of individuals in isolation will be traced. Based on parameter estimates from the scientific literature, the model suggests that proper diagnosis and hence isolation of cases has the highest impact in reducing the size of the outbreak. However, the combination of case isolation and safe funeral practices alone are insufficient to fully contain the epidemic under plausible parameters. This changes if these measures are combined with contact tracing. In addition, shortening the time to successfully trace back contacts contribute substantially to contain the outbreak.Conclusions In the absence of an approved vaccine and treatment, EVD management by proper and fast diagnostics in combination with epidemic awareness are fundamental. Awareness will particularly facilitate contact tracing and safe funeral practices. Moreover, proper and fast diagnostics are a major determinant of case isolation. The model introduced here is not just applicable to EVD, but also to other hemorrhagic diseases such as the MVD or the Lassa fever.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants of the German Academic Exchange (DAAD https://www.daad.de/de/ Project-ID 57417782, Project-ID: 57599539), the Sächsisches Staatsministerium für Wissenschaft, Kultur und Tourismus and Sächsische Aufbaubank - Fӧrderbank (SMWK-SAB https://www.smwk.sachsen.de/ https://www.sab.sachsen.de/ project Innovationsvorhaben zur Profilschärfung an Hochschulen für angewandte Wissenschaften, Project-ID 100257255 project Innovationsvorhaben zur Profilschärfung 2022, Project-ID: 100613388), the Federal Ministry of Education and Research (BMBF), the DLR (Project-ID 01DQ20002 https://www.bmbf.de/ https://www.dlr.de/), and the German Research Foundation (DFG Project ID: SCH 1480/2-1) awarded to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOnly simulated data is reported. The Python code will be made available via GitHub upon publication.